NantHealth, Inc.
NantHealth provides leading solutions across the continuum of care for patients, physicians, payors and biopharmaceutical organizations advancing the promise of precision medicine with evidence based clinical decision support. GPS Cancer sequences tumor-normal DNA plus RNA and reports related therapies and pharmacogenomic impact. Liquid GPS allows non-invasive measurement of cfDNA and cfRNA of specific targets to aid in monitoring and selection of treatment strategies.